Cargando…
LXRα Promotes Hepatosteatosis in Part Through Activation of MicroRNA‐378 Transcription and Inhibition of Ppargc1β Expression
Nonalcoholic fatty liver disease (NAFLD) is a major risk factor of many end‐stage liver diseases. Alterations in microRNA expression have been reported in patients with NAFLD. However, the transcriptional mechanism(s) of dysregulated microRNAs under the state of NAFLD is poorly described, and microR...
Autores principales: | Zhang, Tianpeng, Duan, Jiangyan, Zhang, Lei, Li, Zhuoyu, Steer, Clifford J., Yan, Guiqin, Song, Guisheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6519356/ https://www.ncbi.nlm.nih.gov/pubmed/30281809 http://dx.doi.org/10.1002/hep.30301 |
Ejemplares similares
-
MicroRNA-206 prevents hepatosteatosis and hyperglycemia by facilitating insulin signaling and impairing lipogenesis
por: Wu, Heng, et al.
Publicado: (2016) -
MicroRNA-378a-3p prevents initiation and growth of colorectal cancer by fine tuning polyamine synthesis
por: Liu, Ningning, et al.
Publicado: (2022) -
Activation of microRNA-378a-3p biogenesis promotes hepatic secretion of VLDL and hyperlipidemia by modulating ApoB100-Sortilin1 axis
por: Zhang, Tianpeng, et al.
Publicado: (2020) -
LXR activation potentiates sorafenib sensitivity in HCC by activating microRNA-378a transcription
por: Lin, Zhongjie, et al.
Publicado: (2020) -
Restoration of lipid homeostasis between TG and PE by the LXRα-ATGL/EPT1 axis ameliorates hepatosteatosis
por: Chen, Yulian, et al.
Publicado: (2023)